These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32953228)

  • 41. Asthma medication.
    Rogol PR
    Conn Med; 2008 Aug; 72(7):441. PubMed ID: 18763675
    [No Abstract]   [Full Text] [Related]  

  • 42. Severe asthma in childhood: diagnostic and management challenges.
    Bozzetto S; Carraro S; Zanconato S; Baraldi E
    Curr Opin Pulm Med; 2015 Jan; 21(1):16-21. PubMed ID: 25415405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NICE guidance on omalizumab for severe asthma.
    Diaz RA; Charles Z; George E; Adler AI
    Lancet Respir Med; 2013 May; 1(3):189-90. PubMed ID: 24429120
    [No Abstract]   [Full Text] [Related]  

  • 44. Severe Asthma in Primary Care: Identification and Management.
    Trevor JL; Chipps BE
    Am J Med; 2018 May; 131(5):484-491. PubMed ID: 29355509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [How can asthma in children be controlled?].
    Rousso S; Shoseyov D; Kerem E
    Harefuah; 2013 May; 152(5):299-303, 307. PubMed ID: 23885456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation.
    Bagnasco D; Aloè T; Sclifò F; Ferrantino MG; Marugo F; Arcadipane F; Manfredi A; Canonica GW; Passalacqua G
    Eur Ann Allergy Clin Immunol; 2019 May; 51(3):135-137. PubMed ID: 31081606
    [No Abstract]   [Full Text] [Related]  

  • 47. Severe asthma: When to resort to biological agents.
    Tenero L; Rossignoli S; Piacentini G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():37-39. PubMed ID: 32017206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
    De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
    Trials; 2014 Dec; 15():488. PubMed ID: 25494702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current practices and newer agents for the management of pediatric asthma.
    DeBisschop ME
    JAAPA; 2000 Jun; 13(6):20-2, 25-6, 29-30 passim. PubMed ID: 11503239
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma.
    Han J; Nguyen J; Kim Y; Geng B; Romanowski G; Alejandro L; Proudfoot J; Xu R; Leibel S
    J Asthma; 2019 Mar; 56(3):263-269. PubMed ID: 29672188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controversies in Allergy: Are Biologic Treatment Responses in Severe Asthma the Same in Adults and Children?
    Gaberino CL; Bacharier LB; Jackson DJ
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2673-2682. PubMed ID: 37517797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New guidelines and new therapy options in severe asthma].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):18-9. PubMed ID: 27155682
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of the burden and management of mild asthma in adults - Implications for clinical practice.
    Mulgirigama A; Barnes N; Fletcher M; Pedersen S; Pizzichini E; Tsiligianni I
    Respir Med; 2019 Jun; 152():97-104. PubMed ID: 31128617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
    Sicras-Mainar A; Capel M; Navarro-Artieda R; Nuevo J; Orellana M; Resler G
    J Med Econ; 2020 May; 23(5):492-500. PubMed ID: 31958257
    [No Abstract]   [Full Text] [Related]  

  • 56. Childhood asthma. Balancing efficacy and adherence for optimum management.
    Sveum RJ
    Postgrad Med; 2005 Sep; 118(3):43-50. PubMed ID: 16201308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
    Yang X; Feng HR; Chen ZM; Ying SM
    Chin Med J (Engl); 2018 May; 131(9):1009-1012. PubMed ID: 29692369
    [No Abstract]   [Full Text] [Related]  

  • 58. Treating asthma by the guidelines: developing a medication management information system for use in primary care.
    Twiggs JE; Fifield J; Jackson E; Cushman R; Apter A
    Dis Manag; 2004; 7(3):244-60. PubMed ID: 15669584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical study on bronchial asthma and leukotriene antagonists].
    Yokoyama A
    Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2656-61. PubMed ID: 15658499
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study.
    van Dijk YE; Brandsen MA; Hashimoto S; Rutjes NW; Golebski K; Vermeulen F; Terheggen-Lagro SWJ; van Ewijk BE; der Zee AM; Vijverberg SJH
    Pediatr Pulmonol; 2024 Nov; 59(11):2875-2884. PubMed ID: 38934778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.